Checkpoint Therapeutics, Inc. (CKPT)
NASDAQ: CKPT · Real-Time Price · USD
3.750
+0.380 (11.28%)
At close: Dec 20, 2024, 4:00 PM
3.700
-0.050 (-1.33%)
After-hours: Dec 20, 2024, 7:59 PM EST
Checkpoint Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -46.47 | -51.85 | -62.62 | -56.67 | -23.08 | -24.71 | |
| Stock-Based Compensation | 4.16 | 2.9 | 2.92 | 3.14 | 2.78 | 3.12 | |
| Other Operating Activities | 13.24 | 4.15 | 6.75 | 7.63 | 5.52 | 3.25 | |
| Change in Accounts Receivable | 0.03 | 0.07 | -0.06 | 0 | 0.01 | 1.51 | |
| Change in Accounts Payable | -1.66 | -3.57 | -4.38 | 18.77 | -0.83 | -5.04 | |
| Change in Other Net Operating Assets | -0.06 | 0.7 | -0.17 | 0.83 | -0.94 | 0.51 | |
| Operating Cash Flow | -30.76 | -47.59 | -57.55 | -26.31 | -16.55 | -21.37 | |
| Issuance of Common Stock | 37.13 | 44.76 | 17.62 | 41.28 | 33.28 | 27.57 | |
| Repurchase of Common Stock | - | - | -1.7 | - | - | - | |
| Other Financing Activities | -3.45 | -4.31 | -1.03 | -1.01 | -2.03 | -2.12 | |
| Financing Cash Flow | 33.69 | 40.45 | 14.89 | 40.27 | 31.25 | 25.46 | |
| Net Cash Flow | 2.93 | -7.14 | -42.67 | 13.96 | 14.7 | 4.08 | |
| Free Cash Flow | -30.76 | -47.59 | -57.55 | -26.31 | -16.55 | -21.37 | |
| Free Cash Flow Margin | -65440.43% | -46203.88% | -29976.04% | -9815.67% | -1548.27% | -1251.35% | |
| Free Cash Flow Per Share | -0.67 | -1.72 | -5.60 | -3.11 | -2.96 | -6.05 | |
| Levered Free Cash Flow | -22.81 | -43.27 | -26.97 | -12.72 | -13.56 | -15.37 | |
| Unlevered Free Cash Flow | -22.81 | -43.27 | -26.97 | -12.72 | -13.56 | -15.37 | |
| Change in Net Working Capital | 3.52 | 13.58 | -6.56 | -19.6 | 1.84 | 2.96 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.